Another Reason to Believe Pfizer Could Have a Coronavirus Vaccine Ready in October
"We will go for regulatory approvals in October."
Those were the words of Pfizer (NYSE: PFE) CEO Albert Bourla in a Washington Post live interview earlier this month. He was referring to the prospect that the company, along with its partner BioNTech (NASDAQ: BNTX), could seek approval for COVID-19 vaccine candidate BNT162b2 in the near future.
This statement was consistent with Bourla's previous comments. In July, for example, he told Time magazine that Pfizer expected to know in September whether or not its vaccine works. He added that would pave the way for a quick Food and Drug Administration submission and even approval in October "if we are lucky."
Source Fool.com
